VCG
Vantage Consulting Group’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-488
| Closed | -$229K | – | 176 |
|
|
2024
Q2 | $229K | Sell |
488
-88
| -15% | -$41.2K | 0.17% | 148 |
|
|
2024
Q1 | $241K | Sell |
576
-90
| -14% | -$37.6K | 0.15% | 139 |
|
|
2023
Q4 | $271K | Sell |
666
-12
| -2% | -$4.88K | 0.18% | 96 |
|
|
2023
Q3 | $236K | Sell |
678
-12
| -2% | -$4.17K | 0.16% | 128 |
|
|
2023
Q2 | $243K | Sell |
690
-145
| -17% | -$51K | 0.14% | 140 |
|
|
2023
Q1 | $263K | Buy |
835
+63
| +8% | +$19.8K | 0.15% | 126 |
|
|
2022
Q4 | $223K | Sell |
772
-103
| -12% | -$29.7K | 0.13% | 166 |
|
|
2022
Q3 | $253K | Sell |
875
-70
| -7% | -$20.2K | 0.15% | 106 |
|
|
2022
Q2 | $266K | Sell |
945
-27
| -3% | -$7.6K | 0.15% | 99 |
|
|
2022
Q1 | $254K | Sell |
972
-280
| -22% | -$73.2K | 0.1% | 132 |
|
|
2021
Q4 | $275K | Sell |
1,252
-40
| -3% | -$8.79K | 0.07% | 145 |
|
|
2021
Q3 | $234K | Buy |
1,292
+115
| +10% | +$20.8K | 0.05% | 158 |
|
|
2021
Q2 | $237K | Buy |
+1,177
| New | +$237K | 0.04% | 151 |
|
|
2021
Q1 | – | Sell |
-322
| Closed | -$76K | – | 1546 |
|
|
2020
Q4 | $76K | Buy |
+322
| New | +$76K | 0.01% | 271 |
|